No Love From US: Senate Bill Deals Blow To Aspiring China Biotechs

 
• By Brian Yang

In a bipartisan move, the US Senate is moving to impose new rules on companies - including those from China - seeking US initial public offerings, adding further uncertainty over such plans and further stoking trade tensions.

US dollar and Yuan China which its are 2 biggest countries for economic growth.Now America and China announce tariff tax policy to make conflict.
US BILL TO BLOCK CHINESE COMPANY LISTINGS HURTS BIOTECH IPOs • Source: Shutterstock

More from Financing

More from Business